Clinical Trial Update: Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2a study of iontophoretic dexamethasone phosphate ophthalmic solution for macular edema was terminated. The update does not include safety or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema

Drugs mentioned

• Iontophoretic dexamethasone phosphate ophthalmic solution (dexamethasone phosphate ophthalmic solution)

Snippet

Sponsor: Eyegate Pharmaceuticals, Inc. | Conditions: Macular Edema | Phase 1, Phase 2 | Status: TERMINATED